US50127T1097
US50127T1097
Kura Oncology, Inc.
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 65/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±62.5% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.5x).
Beta (Market Relation)
0.47x
DefensiveVolatility (5Y p.a.)
62.5% p.a.
5-Year HorizonMax Drawdown (5Y)
-76.5%
5-Year HorizonSharpe Ratio
-0.21
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +4.4% |
| 3 Years | 64.3% | -76.5% | 0.04 | +5.1% |
| 5 Years | 62.5% | -76.5% | -0.21 | -10.9% |
| 10 Years | 68.4% | -86.7% | 0.06 | +6.3% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (62.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -86.7% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
7 ISS Score: 7 / 10
Audit Risk
5 ISS Score: 5 / 10
Board Risk
8 ISS Score: 8 / 10
Short Ratio
6.42